Literature DB >> 19068098

Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease.

Gerd Döring1, Erich Gulbins.   

Abstract

Innate immunity is essential for prevention of infection in vertebrates and plants and dysfunction of single components of innate immunity may provoke severe disease. Here we describe how mutations in the cystic fibrosis transmembrane conductance regulator gene dysregulate a variety of components of the innate immune system in individuals suffering from the hereditary disease cystic fibrosis. In the airways of these individuals, functions of the mucociliary clearance system, cationic antimicrobial (poly)peptides and neutrophils and macrophages are impaired and inflammatory signal transduction pathways exaggerated. Consequently, chronic airway colonization with opportunistic bacterial pathogens develops and leads to life-threatening lung disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19068098     DOI: 10.1111/j.1462-5822.2008.01271.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  41 in total

Review 1.  Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions.

Authors:  Charlotte Roy; Manon Launay; Sophie Magréault; Isabelle Sermet-Gaudelus; Vincent Jullien
Journal:  Clin Pharmacokinet       Date:  2021-01-24       Impact factor: 6.447

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 3.  The UPR and lung disease.

Authors:  Fabiola Osorio; Bart Lambrecht; Sophie Janssens
Journal:  Semin Immunopathol       Date:  2013-03-28       Impact factor: 9.623

4.  Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis.

Authors:  Shan-Yu Fung; Vladimir Sofiyev; Julia Schneiderman; Aaron F Hirschfeld; Rachel E Victor; Kate Woods; Jeff S Piotrowski; Raamesh Deshpande; Sheena C Li; Nicole J de Voogd; Chad L Myers; Charlie Boone; Raymond J Andersen; Stuart E Turvey
Journal:  ACS Chem Biol       Date:  2013-10-29       Impact factor: 5.100

5.  Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosis.

Authors:  Thomas P Hofer; Marion Frankenberger; Irene Heimbeck; Dorothe Burggraf; Matthias Wjst; Adam K A Wright; Maria Kerscher; Susanne Nährig; Rudolf M Huber; Rainald Fischer; Loems Ziegler-Heitbrock
Journal:  J Mol Med (Berl)       Date:  2014-08-23       Impact factor: 4.599

Review 6.  Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections.

Authors:  Barbara C Kahl; Karsten Becker; Bettina Löffler
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

7.  Infection of polarized airway epithelial cells by normal and small-colony variant strains of Staphylococcus aureus is increased in cells with abnormal cystic fibrosis transmembrane conductance regulator function and is influenced by NF-κB.

Authors:  Gabriel Mitchell; Gilles Grondin; Ginette Bilodeau; André M Cantin; François Malouin
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

8.  Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator.

Authors:  Ryan T Phennicie; Matthew J Sullivan; John T Singer; Jeffrey A Yoder; Carol H Kim
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

9.  Pathology of gastrointestinal organs in a porcine model of cystic fibrosis.

Authors:  David K Meyerholz; David A Stoltz; Alejandro A Pezzulo; Michael J Welsh
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

Review 10.  Susceptibility to infectious diseases based on antimicrobial peptide production.

Authors:  Bruno Rivas-Santiago; Carmen J Serrano; J Antonio Enciso-Moreno
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.